| Heterobivalent Ligands Crosslink Multiple Cell‐Surface Receptors: The human melanocortin‐4 and δ‐opioid receptors J Vagner, L Xu, HL Handl, JS Josan, DL Morse, EA Mash, RJ Gillies, ... Angewandte Chemie 120 (9), 1709-1712, 2008 | 90 | 2008 |
| Heterobivalent ligands target cell-surface receptor combinations in vivo L Xu, JS Josan, J Vagner, MR Caplan, VJ Hruby, EA Mash, RM Lynch, ... Proceedings of the National Academy of Sciences 109 (52), 21295-21300, 2012 | 83 | 2012 |
| Synthesis and evaluation of bivalent NDP-α-MSH (7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R) HL Handl, R Sankaranarayanan, JS Josan, J Vagner, EA Mash, RJ Gillies, ... Bioconjugate chemistry 18 (4), 1101-1109, 2007 | 80 | 2007 |
| Enhanced targeting with heterobivalent ligands L Xu, J Vagner, J Josan, RM Lynch, DL Morse, B Baggett, H Han, ... Molecular cancer therapeutics 8 (8), 2356-2365, 2009 | 68 | 2009 |
| Cell-specific targeting by heterobivalent ligands JS Josan, HL Handl, R Sankaranarayanan, L Xu, RM Lynch, J Vagner, ... Bioconjugate chemistry 22 (7), 1270-1278, 2011 | 65 | 2011 |
| Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand NM Barkey, NK Tafreshi, JS Josan, CR De Silva, KN Sill, VJ Hruby, ... Journal of medicinal chemistry 54 (23), 8078-8084, 2011 | 62 | 2011 |
| Solid-phase synthesis of heterobivalent ligands targeted to melanocortin and cholecystokinin receptors JS Josan, J Vagner, HL Handl, R Sankaranarayanan, RJ Gillies, VJ Hruby International journal of peptide research and therapeutics 14 (4), 293-300, 2008 | 42 | 2008 |
| MMTV-PyMT and derived Met-1 mouse mammary tumor cells as models for studying the role of the androgen receptor in triple-negative breast cancer progression JL Christenson, KT Butterfield, NS Spoelstra, JD Norris, JS Josan, ... Hormones and Cancer 8 (2), 69-77, 2017 | 39 | 2017 |
| Predictive features of ligand‐specific signaling through the estrogen receptor JC Nwachukwu, S Srinivasan, Y Zheng, S Wang, J Min, C Dong, Z Liao, ... Molecular systems biology 12 (4), 864, 2016 | 36 | 2016 |
| Solid-Phase Synthetic Strategy and Bioevaluation of a Labeled δ-Opioid Receptor Ligand Dmt-Tic-Lys for In Vivo Imaging JS Josan, DL Morse, L Xu, M Trissal, B Baggett, P Davis, J Vagner, ... Organic letters 11 (12), 2479-2482, 2009 | 33 | 2009 |
| Synthesis and biology of new thyrotropin-releasing hormone (TRH) analogues R Jain, J Singh, JH Perlman, MC Gershengorn Bioorganic & medicinal chemistry 10 (1), 189-194, 2002 | 30 | 2002 |
| Fluorescent and lanthanide labeling for ligand screens, assays, and imaging JS Josan, CRD Silva, B Yoo, RM Lynch, MD Pagel, J Vagner, VJ Hruby Drug Design and Discovery, 89-126, 2011 | 29 | 2011 |
| Resazurin live cell assay: Setup and fine-tuning for reliable cytotoxicity results JÁ Rodríguez-Corrales, JS Josan Proteomics for Drug Discovery, 207-219, 2017 | 20 | 2017 |
| Synthesis, receptor binding, and activation studies of N (1)-alkyl-L-histidine containing thyrotropin-releasing hormone (TRH) analogues N Kaur, V Monga, JS Josan, X Lu, MC Gershengorn, R Jain Bioorganic & medicinal chemistry 14 (17), 5981-5988, 2006 | 20 | 2006 |
| Tumor targeting and pharmacokinetics of a near-Infrared fluorescent-labeled δ-opioid receptor antagonist agent, Dmt-Tic-Cy5 AS Huynh, V Estrella, VE Stark, AS Cohen, T Chen, TJ Casagni, JS Josan, ... Molecular pharmaceutics 13 (2), 534-544, 2016 | 14 | 2016 |
| Cancer: Designer antiandrogens join the race against drug resistance JS Josan, JA Katzenellenbogen Elife 2, e00692, 2013 | 8 | 2013 |
| Heterobivalent ligands crosslink multiple cell-surface receptors—a step towards personal medicine JS Josan, R Sankaranarayanan, HL Hand, S Fernandes, L Xu, J Vagner, ... Peptides for Youth, 413-414, 2009 | 4 | 2009 |
| Separation of stereoisomers of 7-oxa-bicyclo [2.2. 1] heptene sulfonate (obhs), a selective estrogen receptor modulator (serm), via chiral stationary phases using sfc/uv and sfc/ms P Balasubramanyam, M Ashraf-Khorassani, JS Josan Journal of Chromatography B 1092, 279-285, 2018 | 3 | 2018 |
| Heteromultivalent ligands directed targeting of cell-surface receptors—Implications in cancer diagnostics & therapeutics JS Josan The University of Arizona, 2008 | 3 | 2008 |
| New approaches to the design, synthesis and biochemical and biophysical evaluation of heteromultivalent ligands for detection and treatment of cancer V Hruby, J Josan, J Vagner, S Fernandes, H Handl, L Xu, L Ronald, ... Journal of Peptide Science 14 (8), 23-23, 2008 | 2 | 2008 |
